Integrin αV-mediated activation of TGF-β also promotes tumour progression through multiple pathways including epithelial-to-mesenchymal transition, an increase of angiogenesis and invasion, formation of cancer-associated fibroblasts, and suppression of T cell-mediated immune surveillance34,35. The gene discussed is TGFB1; the disease is cancer.